Myovant hormonal therapy gets FDA nod, setting up competition with AbbVie May 27, 2021 Auto Bot BioPharma, Clinical Trials, FDA, Legal, Myovant, Pfizer, Pharma, Relugolix, Uterine Fibroids, womens health 0 Myovant hormonal drug Myfembree has won FDA approval as a treatment for uterine fibroid bleeding. The regulatory decision clears the way for the pill to compete against a similar AbbVie drug, but with dosing and pricing advantages.